WHO prequalifies new dengue vaccine WHO May 16, 2024 WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission intensity
Phase III efficacy clinical study results of Sanofi’s Dengue vaccine candidate published EP News Bureau Nov 4, 2014 Study successfully met primary objective and confirms high efficacy against severe dengue and hospitalisation
